Denis is Managing Partner of Sofinnova Partners where he has built a strong track record in the life science and AgTech sectors through successful financing rounds and exits, including Innate Pharma, Ablynx (acquired by Sanofi) and CropDesign (acquired by BASF). He recently specialized in Industrial Biotech with investments in BioAmber and Avantium (both went public on NYSE and Euronext Amsterdam respectively) and in Green Biologics and Biotalys. Denis began his career in academic research and was responsible for the technology transfer department of the Institut National de la Recherche Agronomique (INRA). Denis was also the Chairman of Sofinnova Partners between 2007 and 2017, and founded in 1997 the French Association for Biotech Entrepreneurs, France Biotech. He is a Graduate in Engineering from Ecole Polytechnique and Ecole du Génie Rural des Eaux et Forêts, France. He has a Degree in Innovation Management from the Université de Paris-Dauphine, France.